© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Latest Conference Articles
NAFLD is Now MASLD: The New Nomenclature, At-a-Glance
November 8th 2023
The shift in naming for diseases historically known as nonalcoholic fatty liver disease will be top of mind at The Liver Meeting 2023. Get a quick look at why.
The Liver Meeting 2023: AASLD Offers "Journey Maps" to Focused Areas of Interest
November 6th 2023
We took The Liver Meeting's 11 journey maps to educational sessions and focused on 4 that will be of interest to primary care.
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
October 25th 2023
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
Universal Masking in Health Care Settings: Poised for Return?
October 18th 2023
IDWeek 2023: Infectious disease specialist, Gopi Patel, MD, discusses universal masking in health care settings.
ID Specialist Underscores Vital Role of Vaccination among Health Care Professionals this Flu Season at IDWeek 2023
October 17th 2023
Clinicians must remember the point of vaccines was not to prevent infection, but to decrease severity of illness, says infectious disease specialist Gopi Patel, MD.
ID Specialist to Colleagues: Don’t Pass Your Germs to Your Patients This Flu Season
October 17th 2023
Gopi Patel, MD, emphasizes the importance of promoting vaccination and infection prevention measures among fellow clinicians, as well as patients, this season.
IDWeek 2023 Chair on Primary Care: "Central to Every Health Outcome We Have in the US..."
October 17th 2023
IDWeek chair Heather Yun, MD, observed that "primary care clinicians are out in front of all things," and that job is big and it's hard.
Heather Yun, MD, IDWeek 2023 Chair, Says Emerging Threats May be Bigger than Pathogens
October 16th 2023
IDWeek 2023 chair Yun points to climate change and other human-driven devastation of the biosphere as the global threats that will cause disease at local levels.
IDWeek 2023: Nirsevimab Efficacy Against RSV-LRTI-Associated Hospitalization is Robust Across Infant Subgroups
October 15th 2023
IDWeek 2023. Nirsevimab efficacy was significant across infant subgroups in preventing hospitalization for RSV-LRTI during a first RSV season.
IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP
October 15th 2023
IDWeek 2023. New study found just slightly more than half of prescriptions for cabotegravir for HIV PrEP resulted in at least 1 injection, suggesting limitations in use and access to the injectable HIV integrase inhibitor.